Cancer Research Donn Young  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riggi, N.
Right arrow Articles by Stamenkovic, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riggi, N.
Right arrow Articles by Stamenkovic, I.
[Cancer Research 65, 11459-11468, December 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells

Nicolò Riggi1, Luisa Cironi1, Paolo Provero2, Mario-Luca Suvà1, Konstantinos Kaloulis3, Carlos Garcia-Echeverria4, Francesco Hoffmann4, Andreas Trumpp3 and Ivan Stamenkovic1

1 Experimental Pathology Division, Institute of Pathology, University of Lausanne, Lausanne, Switzerland; 2 Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy; 3 Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland; and 4 Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland

Requests for reprints: Ivan Stamenkovic, Experimental Pathology Division, Institute of Pathology, University of Lausanne, CH-1011 Lausanne, Switzerland. Phone: 41-21-314-7136; Fax: 41-21-314-7110; E-mail: Ivan.Stamenkovic{at}chuv.hospvd.ch.

Ewing's sarcoma is a member of Ewing's family tumors (EFTs) and the second most common solid bone and soft tissue malignancy of children and young adults. It is associated in 85% of cases with the t(11;22)(q24:q12) chromosomal translocation that generates fusion of the 5' segment of the EWS gene with the 3' segment of the ETS family gene FLI-1. The EWS-FLI-1 fusion protein behaves as an aberrant transcriptional activator and is believed to contribute to EFT development. However, EWS-FLI-1 induces growth arrest and apoptosis in normal fibroblasts, and primary cells that are permissive for its putative oncogenic properties have not been discovered, hampering basic understanding of EFT biology. Here, we show that EWS-FLI-1 alone can transform primary bone marrow–derived mesenchymal progenitor cells and generate tumors that display hallmarks of Ewing's sarcoma, including a small round cell phenotype, expression of EFT-associated markers, insulin like growth factor-I dependence, and induction or repression of numerous EWS-FLI-1 target genes. These observations provide the first identification of candidate primary cells from which EFTs originate and suggest that EWS-FLI-1 expression may constitute the initiating event in EFT pathogenesis. (Cancer Res 2005; 65(24): 11459-68)




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. L. Ordonez, D. Osuna, D. Herrero, E. de Alava, and J. Madoz-Gurpide
Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
Cancer Res., September 15, 2009; 69(18): 7140 - 7150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Gjerstorff, J. S. Burns, O. Nielsen, M. Kassem, and H. Ditzel
Epigenetic Modulation of Cancer-Germline Antigen Gene Expression in Tumorigenic Human Mesenchymal Stem Cells: Implications for Cancer Therapy
Am. J. Pathol., July 1, 2009; 175(1): 314 - 323.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
R. HUHN, M. S. STAEGE, M. HESSE, B. LIEBIG, and S. E.G. BURDACH
Cleavage of the Ewing Tumour-specific EWSR1-FLI1 mRNA by Hammerhead Ribozymes
Anticancer Res, June 1, 2009; 29(6): 1901 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. H. S. Richter, S. Plehm, A. Fasan, S. Rossler, R. Unland, I. M. Bennani-Baiti, M. Hotfilder, D. Lowel, I. von Luettichau, I. Mossbrugger, et al.
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
PNAS, March 31, 2009; 106(13): 5324 - 5329.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
H. Kubo, M. Shimizu, Y. Taya, T. Kawamoto, M. Michida, E. Kaneko, A. Igarashi, M. Nishimura, K. Segoshi, Y. Shimazu, et al.
Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry
Genes Cells, March 1, 2009; 14(3): 407 - 424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M.-L. Suva, N. Riggi, J.-C. Stehle, K. Baumer, S. Tercier, J.-M. Joseph, D. Suva, V. Clement, P. Provero, L. Cironi, et al.
Identification of Cancer Stem Cells in Ewing's Sarcoma
Cancer Res., March 1, 2009; 69(5): 1776 - 1781.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. P. Lin, M. K. Pandey, F. Jin, S. Xiong, M. Deavers, J. M. Parant, and G. Lozano
EWS-FLI1 Induces Developmental Abnormalities and Accelerates Sarcoma Formation in a Transgenic Mouse Model
Cancer Res., November 1, 2008; 68(21): 8968 - 8975.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Ban, I. M. Bennani-Baiti, M. Kauer, K.-L. Schaefer, C. Poremba, G. Jug, R. Schwentner, O. Smrzka, K. Muehlbacher, D. N.T. Aryee, et al.
EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma
Cancer Res., September 1, 2008; 68(17): 7100 - 7109.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-X. Ren, F. G. Finckenstein, D. A. Abdueva, V. Shahbazian, B. Chung, K. I. Weinberg, T. J. Triche, H. Shimada, and M. J. Anderson
Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Cancer Res., August 15, 2008; 68(16): 6587 - 6597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Riggi, M.-L. Suva, D. Suva, L. Cironi, P. Provero, S. Tercier, J.-M. Joseph, J.-C. Stehle, K. Baumer, V. Kindler, et al.
EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
Cancer Res., April 1, 2008; 68(7): 2176 - 2185.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Miyagawa, H. Okita, H. Nakaijima, Y. Horiuchi, B. Sato, T. Taguchi, M. Toyoda, Y. U. Katagiri, J. Fujimoto, J.-i. Hata, et al.
Inducible Expression of Chimeric EWS/ETS Proteins Confers Ewing's Family Tumor-Like Phenotypes to Human Mesenchymal Progenitor Cells
Mol. Cell. Biol., April 1, 2008; 28(7): 2125 - 2137.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. C. Torchia, K. Boyd, J. E. Rehg, C. Qu, and S. J. Baker
EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice
Mol. Cell. Biol., November 15, 2007; 27(22): 7918 - 7934.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. P. Hill and R. Perris
"Destemming" Cancer Stem Cells
J Natl Cancer Inst, October 3, 2007; 99(19): 1435 - 1440.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Merlino and C. Khanna
Fishing for the origins of cancer
Genes & Dev., June 1, 2007; 21(11): 1275 - 1279.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Baliko, T. Bright, R. Poon, B. Cohen, S. E. Egan, and B. A. Alman
Inhibition of Notch Signaling Induces Neural Differentiation in Ewing Sarcoma
Am. J. Pathol., May 1, 2007; 170(5): 1686 - 1694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. F. Zhou, M. Bosch-Marce, H. Okuyama, B. Krishnamachary, H. Kimura, L. Zhang, D. L. Huso, and G. L. Semenza
Spontaneous Transformation of Cultured Mouse Bone Marrow-Derived Stromal Cells.
Cancer Res., November 15, 2006; 66(22): 10849 - 10854.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kovar and A. Bernard
CD99-Positive "Ewing's Sarcoma" from Mouse Bone Marrow-Derived Mesenchymal Progenitor Cells?
Cancer Res., October 1, 2006; 66(19): 9786 - 9786.
[Full Text] [PDF]


Home page
Cancer Res.Home page
N. Riggi, M.-L. Suva, and I. Stamenkovic
Ewing's Sarcoma-Like Tumors Originate from EWS-FLI-1-Expressing Mesenchymal Progenitor Cells
Cancer Res., October 1, 2006; 66(19): 9786 - 9786.
[Full Text] [PDF]


Home page
Cancer Res.Home page
N. Riggi, L. Cironi, P. Provero, M.-L. Suva, J.-C. Stehle, K. Baumer, L. Guillou, and I. Stamenkovic
Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma.
Cancer Res., July 15, 2006; 66(14): 7016 - 7023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.